Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02525731 · ClinicalTrials.gov registry record
Targeting Effective Analgesia in Clinics for HIV - Patient Cohort
A clinical trial, sponsored by Boston Medical Center.
- Completed
- Registry status
- 170
- Enrollment target
NCT02525731 is a clinical trial that has completed, run by Boston Medical Center. The registered enrollment target is 170 participants.
The verdict
NCT02525731 has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- 170 participants
- Enrollment target
Study Summary
The TEACH patient cohort will characterize a clinic sample of HIV-infected patients on chronic opioid therapy (COT) by describing basic demographics and health status, including characteristics of pain (severity and interference), aberrant behaviors/misuse of COT, substance use and trust/satisfaction with providers. In addition, data on a subset of participants will be used to supplement analysis of secondary outcomes for the TEACH randomized controlled trial (RCT), an intervention study directed at COT providers (outlined in a separate Clinical Trials Protocol Registration and Results (PRS) summary).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2015-07 |
| Est. Completion | 2018-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02525731
The ClinicalTrials.gov registry entry for NCT02525731 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02525731 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02525731 about?
NCT02525731 is a clinical study titled "Targeting Effective Analgesia in Clinics for HIV - Patient Cohort". The TEACH patient cohort will characterize a clinic sample of HIV-infected patients on chronic opioid therapy (COT) by describing basic demographics and health status, including characteristics of pain (severity and interference), aberrant behaviors/misuse of COT, substance use and trust/satisfactio...
What is the current status of trial NCT02525731?
This trial is currently completed. The enrollment target is 170 participants. The study started on 2015-07. Estimated completion is 2018-11.
Who is sponsoring clinical trial NCT02525731?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.